Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/30/18
End: 01/09/19
Due: 01/09/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of APX3330 in Patients With Advanced Solid Tumors | NCT03375086 | Apexian Pharmaceuticals, Inc. | user2@example.com | None | 2018-01-30 | 2019-01-09 | 2020-01-09 | - | - | 2025-07-14 |